Chronic Obstructive Pulmonary Disease (COPD)
Together, We Could Breathe New Life Into COPD Care
Living with chronic obstructive pulmonary disease (COPD) can be hard. But, by working together, we might be able to improve the quality of life for those living with the disease. That’s why we’re looking for diverse volunteers to take part in a clinical trial that will assess how safe and effective a new investigational drug is in reducing COPD flare-ups or exacerbations.
To qualify, you must:
- Be between the ages of 40 and 80 years old
- Be diagnosed with COPD for at least 1 year
- Have had two or more moderate or severe exacerbations in the last year
- A moderate COPD exacerbation is defined as new or increased COPD symptoms that need treatment with steroids and/or antibiotics
- A severe COPD exacerbation is defined as new or increased COPD symptoms that lead to hospitalization (for more than 24 hours)
- Be a current tobacco smoker or former smoker
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.